Constant Gillot

Namur, WAL 5000, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Flow cytometry-based characterization of isolated human neutrophils: Evaluating viability, purity and defining a reference interval for basal activation in functional assays.

Flow cytometry-based characterization of isolated human neutrophils: Evaluating viability, purity and defining a reference interval for basal activation in functional assays.

Journal: Journal of immunological methods

Published: April 07, 2026

Rethinking hemocompatibility standards: a critical appraisal of current regulatory frameworks for Advanced Therapy Medicinal Products (ATMPs) validation.

Rethinking hemocompatibility standards: a critical appraisal of current regulatory frameworks for Advanced Therapy Medicinal Products (ATMPs) validation.

Journal: Acta biomaterialia

Published: April 07, 2026

Sialylated porphyrins optimized as anti-infective agents against SARS-CoV-2 variants.

Sialylated porphyrins optimized as anti-infective agents against SARS-CoV-2 variants.

Journal: Bioorganic chemistry

Published: December 03, 2025

Techniques for measuring NETosis: A critical literature review and outlook for standardization.

Techniques for measuring NETosis: A critical literature review and outlook for standardization.

Journal: Thrombosis research

Published: November 25, 2025

Device-Induced Thrombosis in Blood-Contacting Medical Devices: Mechanisms and Emerging Prevention Strategies.

Device-Induced Thrombosis in Blood-Contacting Medical Devices: Mechanisms and Emerging Prevention Strategies.

Journal: Advanced healthcare materials

Published: November 03, 2025

Evaluation of NETosis Inhibitors in a Laboratory-Developed ex-vivo Human Neutrophil Model.

Evaluation of NETosis Inhibitors in a Laboratory-Developed ex-vivo Human Neutrophil Model.

Journal: Journal of inflammation research

Published: October 02, 2025

Evaluation of neutralizing antibody titers against SARS-CoV-2 JN.1 omicron subvariant during pregnancy - A case series study.

Evaluation of neutralizing antibody titers against SARS-CoV-2 JN.1 omicron subvariant during pregnancy - A case series study.

Journal: Heliyon

Published: October 01, 2024

Neutralizing antibodies against KP.2 and KP.3: why the current vaccine needs an update.

Neutralizing antibodies against KP.2 and KP.3: why the current vaccine needs an update.

Journal: Clinical chemistry and laboratory medicine

Published: August 08, 2024

Vaccine-induced humoral response of BNT162b2 and mRNA-1273 against BA.1, BA.5, and XBB.1.5. (sub)variants 6 months after a homologous booster: is immunogenicity equivalent?

Vaccine-induced humoral response of BNT162b2 and mRNA-1273 against BA.1, BA.5, and XBB.1.5. (sub)variants 6 months after a homologous booster: is immunogenicity equivalent?

Journal: Heliyon

Published: February 02, 2024

Neutralizing antibody response to XBB.1.5, BA.2.86, FL.1.5.1, and JN.1 six months after the BNT162b2 bivalent booster.

Neutralizing antibody response to XBB.1.5, BA.2.86, FL.1.5.1, and JN.1 six months after the BNT162b2 bivalent booster.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: January 16, 2024

Evaluation of Neutralizing Capacity of Tixagevimab plus Cilgavimab (AZD7442) against Different SARS-CoV-2 Variants: A Case Report Study with Comparison to a Vaccinated Population.

Evaluation of Neutralizing Capacity of Tixagevimab plus Cilgavimab (AZD7442) against Different SARS-CoV-2 Variants: A Case Report Study with Comparison to a Vaccinated Population.

Journal: Case reports in infectious diseases

Published: December 11, 2023

Assessment of the neutralizing antibody response in Omicron breakthrough cases in healthcare workers who received the homologous booster of Moderna mRNA-1273.

Assessment of the neutralizing antibody response in Omicron breakthrough cases in healthcare workers who received the homologous booster of Moderna mRNA-1273.

Journal: Virology

Published: November 24, 2023

Showing 1-12 of 36

Last Updated: 09/26/2026